Most Popular Stories
- Ben Venue can't say when crucial cancer drug will be available
- Gene study finds tumor-cell flaw possibly vulnerable to Pfizer, AZ cancer meds
- Ben Venue's idled plant triggers 'dire' leukemia-drug shortage
- Novartis dealt another setback to broader Menveo use
- Curcumin, in Indian curry spice, may beat down prostate tumors
- Key protein appears to kill off HIV food supply in certain cells
- GSK studies Chinese remedies to discover new drugs
- Chelsea shares nosedive on FDA's questions about key drug
- DNA sequencing exposes new uses for Pfizer targeted cancer drugs
- Preclinical study triggers 'massive response' from desperate Alzheimer's patients
- Hungry Valeant snags Eyetech in ongoing buyout spree
Webinars
- Active Directory & the Cloud for Biotech & PharmaBiotech and pharmaceutical companies are leaders cloud/SaaS technology adoption. This webi
- Drug Development: An Overview of the Regulated Clinical Trials Process Used to Bring a New Drug to MarketJoin us for a one-hour overview of the regulated clinical trials process used to bring a n
- Inside the mHealth Revolution with Welch Allyn: Realizing the Potential of Connected DevicesAfter launching a line of connected devices, Welch Allyn immediately viewed it as an oppor
- Biomarkers and Translational Medicine in Early Phase Oncology Clinical Development (Part two of our three part series) Increasingly, new technologies are making it possible to carefully identify sets of patien
Featured Jobs
-
Clinical Research Associate
Jennerex, Inc - San Francisco, CA -
Docket Clerk Job
Celgene Corporation - Summit, NJ, US -
Manager, Business Development
Clinical Resource Network - Chicago, IL -
Benefits Specialist Job
Celgene Corporation - Summit, NJ, US -
Product Manager, Channel Marketing Job
Celgene Corporation - Summit, NJ, US
Events
- DCAT Week '12 Biologics Forum & Networking Reception
Mar 14 — New York City - Live Web Conference: Risk Management of Adventitious Agent Contamination
March 21 - Euro-Biotech Partnering Summit
May 30-June 1, 2012 — Paris, France - DCAT Week 2012
Mar 12-15 — New York City
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- Forum Signature File : solution for Media Marketing
- Best Practices: ERP Vendor Reference-Checking
- The National Provider Identifier (NPI) and its Impact on the Pharmaceutical and Medical Device Industries
- Why the Next Big Fortune Could Be Made in… Curitiba?
- API in Capsule: Common "First in Man" approaches vs. The Lost Art of Formulation Development
- Launching a Medical Device, Healthcare or Life Science Product: Fail Fast, Marginal or Worth Pursuing?
Articles by Calisha Myers
- October 7, 2009
- October 7, 2009
- October 2, 2009
- October 1, 2009
- October 1, 2009
- October 1, 2009
- October 1, 2009
- October 1, 2009
- October 1, 2009
- October 1, 2009
- October 1, 2009
- October 1, 2009
- October 1, 2009
- October 1, 2009
- October 1, 2009
- October 1, 2009
- October 1, 2009
- October 1, 2009
- October 1, 2009
- September 30, 2009
- September 29, 2009
- September 25, 2009
- September 25, 2009
- September 24, 2009
- September 23, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
